In GBM, we found that the high expressions of 25 genes activate or inhibit eight cancer-related pathways, namely, TSC/mTOR, hormone AR, hormone ER, DNA damage response, RTK, EMT, apoptosis, and cell cycle (FDR < 0.05) (Supplementary Figure S4B). Here, MTOR is linked to glioblastoma.